Cell therapy treats disease using living cells. These cells can be taken from a patient or a healthy donor and are specially prepared to help the body heal, fight illness, or restore function. Some cell therapies work by replacing damaged cells, while others guide the immune system to restore balance. As science moves forward, cell therapy is opening new doors for patients with serious and complex conditions.
For many patients and families, the answer to “What is cell therapy?” comes through lived experience. When no other options were left, cell therapy offered Emily a path forward.
Over ten years ago, six-year-old Emily Whitehead became one of the first pediatric patients to receive CAR-T therapy for leukemia. Today, more than a decade later, Emily remains cancer-free.
Her story shows the true potential of cell therapy to restore hope, health, and possibility.
How Patients Receive Cell Therapy
Cell therapy uses living cells to treat disease, but they don’t all work the same way. Some are made from a patient’s own cells (autologous), and others come from healthy donors (allogeneic). Common approaches include immune cell therapies like CAR-T, bone marrow and blood stem cell transplants, and stem cells that can help repair tissue.
Each type brings unique considerations for manufacturing and delivery. Many therapies must be produced over several weeks and given within days under strict conditions, making timing and logistics difficult.
On the Horizon for Cell Therapy
Delivering cell therapies reliably requires solving challenges of storage, transport, and administration, as well as scaling both patient- and donor-derived products. New approaches, such as lab-grown induced pluripotent stem cells (iPSCs), could create off the shelf treatments that reach more patients.
To help advance this progress, ARM convenes developers, regulators, and providers, facilitates efforts like A-Cell, and shares insights through resources such as our immuno-oncology workshop white paper.
Discover how technologies like CRISPR enable precise, targeted changes to the genome, offering durable solutions for monogenic diseases.
Explore how gene therapy inserts, modifies, or replaces genetic material to correct inherited conditions or treat acquired diseases at the molecular level.
Understand how regenerative products rebuild, replace, or support damaged tissues, including skin, cartilage, and corneal grafts.
Sign up for ARM’s weekly newsletter on sector news and alerts for events, reports, and other engagement opportunities.
